Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Positive effects of acupressure bands combined with relaxation music/instructions on patients most at risk for chemotherapy-induced nausea.

Peoples AR, Culakova E, Heckler CE, Shayne M, O'Connor TL, Kirshner JJ, Bushunow PW, Morrow GR, Roscoe JA.

Support Care Cancer. 2019 Mar 30. doi: 10.1007/s00520-019-04736-x. [Epub ahead of print]

PMID:
30929028
2.

Cancer During Pregnancy: The Oncologist Overview.

Hepner A, Negrini D, Hase EA, Exman P, Testa L, Trinconi AF, Filassi JR, Francisco RPV, Zugaib M, O'Connor TL, Martin MG.

World J Oncol. 2019 Feb;10(1):28-34. doi: 10.14740/wjon1177. Epub 2019 Feb 26. Review.

3.

Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

Denlinger CS, Sanft T, Baker KS, Broderick G, Demark-Wahnefried W, Friedman DL, Goldman M, Hudson M, Khakpour N, King A, Koura D, Lally RM, Langbaum TS, McDonough AL, Melisko M, Montoya JG, Mooney K, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Peppercorn J, Pirl W, Rodriguez MA, Ruddy KJ, Silverman P, Smith S, Syrjala KL, Tevaarwerk A, Urba SG, Wakabayashi MT, Zee P, McMillian NR, Freedman-Cass DA.

J Natl Compr Canc Netw. 2018 Oct;16(10):1216-1247. doi: 10.6004/jnccn.2018.0078.

4.

Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

Denlinger CS, Sanft T, Baker KS, Baxi S, Broderick G, Demark-Wahnefried W, Friedman DL, Goldman M, Hudson M, Khakpour N, King A, Koura D, Kvale E, Lally RM, Langbaum TS, Melisko M, Montoya JG, Mooney K, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Peppercorn J, Rodriguez MA, Ruddy KJ, Silverman P, Smith S, Syrjala KL, Tevaarwerk A, Urba SG, Wakabayashi MT, Zee P, Freedman-Cass DA, McMillian NR.

J Natl Compr Canc Netw. 2017 Sep;15(9):1140-1163. doi: 10.6004/jnccn.2017.0146.

5.

Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial.

Himelstein AL, Foster JC, Khatcheressian JL, Roberts JD, Seisler DK, Novotny PJ, Qin R, Go RS, Grubbs SS, O'Connor T, Velasco MR Jr, Weckstein D, O'Mara A, Loprinzi CL, Shapiro CL.

JAMA. 2017 Jan 3;317(1):48-58. doi: 10.1001/jama.2016.19425.

6.

Clinical outcomes in patients with brain metastases from breast cancer treated with single-session radiosurgery or whole brain radiotherapy.

Mix M, Elmarzouky R, O'Connor T, Plunkett R, Prasad D.

J Neurosurg. 2016 Dec;125(Suppl 1):26-30.

PMID:
27903186
7.

NCCN Guidelines Insights: Older Adult Oncology, Version 2.2016.

VanderWalde N, Jagsi R, Dotan E, Baumgartner J, Browner IS, Burhenn P, Cohen HJ, Edil BH, Edwards B, Extermann M, Ganti AK, Gross C, Hubbard J, Keating NL, Korc-Grodzicki B, McKoy JM, Medeiros BC, Mrozek E, O'Connor T, Rugo HS, Rupper RW, Shepard D, Silliman RA, Stirewalt DL, Tew WP, Walter LC, Wildes T, Bergman MA, Sundar H, Hurria A.

J Natl Compr Canc Netw. 2016 Nov;14(11):1357-1370.

PMID:
27799507
8.

NCCN Guidelines Insights: Survivorship, Version 1.2016.

Denlinger CS, Ligibel JA, Are M, Baker KS, Broderick G, Demark-Wahnefried W, Friedman DL, Goldman M, Jones LW, King A, Ku GH, Kvale E, Langbaum TS, McCabe MS, Melisko M, Montoya JG, Mooney K, Morgan MA, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Peppercorn J, Rodriguez MA, Ruddy KJ, Sanft T, Silverman P, Smith S, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian NR, Freedman-Cass DA.

J Natl Compr Canc Netw. 2016 Jun;14(6):715-24.

9.

Safety and tolerability of docetaxel, cyclophosphamide, and trastuzumab compared to standard trastuzumab-based chemotherapy regimens for early-stage human epidermal growth factor receptor 2-positive breast cancer.

Jitawatanarat P, O'Connor TL, Kossoff EB, Levine EG, Chittawatanarat K, Ngamphaiboon N.

J Breast Cancer. 2014 Dec;17(4):356-62. doi: 10.4048/jbc.2014.17.4.356. Epub 2014 Dec 26.

10.

Survivorship: screening for cancer and treatment effects, version 2.2014.

Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Dizon D, Friedman DL, Goldman M, Jones L, King A, Ku GH, Kvale E, Langbaum TS, Leonardi-Warren K, McCabe MS, Melisko M, Montoya JG, Mooney K, Morgan MA, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Peppercorn J, Raza M, Rodriguez MA, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian NR, Freedman-Cass DA.

J Natl Compr Canc Netw. 2014 Nov;12(11):1526-31.

11.

Hospice utilization and end-of-life care in metastatic breast cancer patients at a comprehensive cancer center.

O'Connor TL, Ngamphaiboon N, Groman A, Luczkiewicz DL, Kuszczak SM, Grant PC, Kerr CW.

J Palliat Med. 2015 Jan;18(1):50-5. doi: 10.1089/jpm.2014.0238.

PMID:
25353618
12.

Survivorship: nutrition and weight management, Version 2.2014. Clinical practice guidelines in oncology.

Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Dizon D, Friedman DL, Goldman M, Jones L, King A, Ku GH, Kvale E, Langbaum TS, Leonardi-Warren K, McCabe MS, Melisko M, Montoya JG, Mooney K, Morgan MA, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Peppercorn J, Raza M, Rodriguez MA, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian NR, Freedman-Cass DA; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2014 Oct;12(10):1396-406.

13.

Survivorship: healthy lifestyles, version 2.2014.

Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Dizon D, Friedman DL, Goldman M, Jones L, King A, Ku GH, Kvale E, Langbaum TS, Leonardi-Warren K, McCabe MS, Melisko M, Montoya JG, Mooney K, Morgan MA, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Peppercorn J, Raza M, Rodriguez MA, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian NR, Freedman-Cass DA; National comprehensive cancer network.

J Natl Compr Canc Netw. 2014 Sep;12(9):1222-37.

14.

Survivorship: immunizations and prevention of infections, version 2.2014.

Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Dizon D, Friedman DL, Goldman M, Jones L, King A, Ku GH, Kvale E, Langbaum TS, Leonardi-Warren K, McCabe MS, Melisko M, Montoya JG, Mooney K, Morgan MA, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Peppercorn J, Raza M, Rodriguez MA, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian NR, Freedman-Cass DA.

J Natl Compr Canc Netw. 2014 Aug;12(8):1098-111.

15.

Survivorship: cognitive function, version 1.2014.

Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Friedman DL, Goldman M, Jones L, King A, Ku GH, Kvale E, Langbaum TS, Leonardi-Warren K, McCabe MS, Melisko M, Montoya JG, Mooney K, Morgan MA, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Raza M, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian NR, Freedman-Cass DA; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2014 Jul;12(7):976-86.

16.

Survivorship: fatigue, version 1.2014.

Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Friedman DL, Goldman M, Jones L, King A, Ku GH, Kvale E, Langbaum TS, Leonardi-Warren K, McCabe MS, Melisko M, Montoya JG, Mooney K, Morgan MA, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Raza M, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian N, Freedman-Cass D.

J Natl Compr Canc Netw. 2014 Jun;12(6):876-87.

17.

Survivorship: sleep disorders, version 1.2014.

Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Friedman DL, Goldman M, Jones L, King A, Ku GH, Kvale E, Langbaum TS, Leonardi-Warren K, McCabe MS, Melisko M, Montoya JG, Mooney K, Morgan MA, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Raza M, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian N, Freedman-Cass D; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2014 May;12(5):630-42.

18.

Survivorship: pain version 1.2014.

Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Friedman DL, Goldman M, Jones L, King A, Ku GH, Kvale E, Langbaum TS, Leonardi-Warren K, McCabe MS, Melisko M, Montoya JG, Mooney K, Morgan MA, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Raza M, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian N, Freedman-Cass D; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2014 Apr;12(4):488-500.

19.

Survivorship: sexual dysfunction (male), version 1.2013.

Denlinger CS, Carlson RW, Are M, Baker KS, Davis E, Edge SB, Friedman DL, Goldman M, Jones L, King A, Kvale E, Langbaum TS, Ligibel JA, McCabe MS, McVary KT, Melisko M, Montoya JG, Mooney K, Morgan MA, O'Connor T, Paskett ED, Raza M, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian N, Freedman-Cass D; National comprehensive cancer network.

J Natl Compr Canc Netw. 2014 Mar 1;12(3):356-63.

20.

Survivorship: sexual dysfunction (female), version 1.2013.

Denlinger CS, Carlson RW, Are M, Baker KS, Davis E, Edge SB, Friedman DL, Goldman M, Jones L, King A, Kvale E, Langbaum TS, Ligibel JA, McCabe MS, McVary KT, Melisko M, Montoya JG, Mooney K, Morgan MA, O'Connor T, Paskett ED, Raza M, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian N, Freedman-Cass D; National compresensive cancer network.

J Natl Compr Canc Netw. 2014 Feb;12(2):184-92.

21.

Managing breast cancer in the older patient.

O'Connor T, Shinde A, Doan C, Katheria V, Hurria A.

Clin Adv Hematol Oncol. 2013 Jun;11(6):341-7. Review.

22.

Senior adult oncology, version 2.2014: clinical practice guidelines in oncology .

Hurria A, Wildes T, Blair SL, Browner IS, Cohen HJ, Deshazo M, Dotan E, Edil BH, Extermann M, Ganti AK, Holmes HM, Jagsi R, Karlekar MB, Keating NL, Korc-Grodzicki B, McKoy JM, Medeiros BC, Mrozek E, O'Connor T, Rugo HS, Rupper RW, Silliman RA, Stirewalt DL, Tew WP, Walter LC, Weir AB 3rd, Bergman MA, Sundar H.

J Natl Compr Canc Netw. 2014 Jan;12(1):82-126.

PMID:
24453295
23.

Survivorship: introduction and definition. Clinical practice guidelines in oncology.

Denlinger CS, Carlson RW, Are M, Baker KS, Davis E, Edge SB, Friedman DL, Goldman M, Jones L, King A, Kvale E, Langbaum TS, Ligibel JA, McCabe MS, McVary KT, Melisko M, Montoya JG, Mooney K, Morgan MA, O'Connor T, Paskett ED, Raza M, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian N, Freedman-Cass D.

J Natl Compr Canc Netw. 2014 Jan;12(1):34-45.

24.

NY-ESO-1 cancer testis antigen demonstrates high immunogenicity in triple negative breast cancer.

Ademuyiwa FO, Bshara W, Attwood K, Morrison C, Edge SB, Karpf AR, James SA, Ambrosone CB, O'Connor TL, Levine EG, Miliotto A, Ritter E, Ritter G, Gnjatic S, Odunsi K.

PLoS One. 2012;7(6):e38783. doi: 10.1371/journal.pone.0038783. Epub 2012 Jun 28. Erratum in: PLoS One.2012;7(8). doi:10.1371/annotation/5cdf6105-2a52-497a-86b3-db8f4a4e439c. Karpf, Adam R [added]; James, Smith A [added].

25.

Senior adult oncology.

Hurria A, Browner IS, Cohen HJ, Denlinger CS, deShazo M, Extermann M, Ganti AK, Holland JC, Holmes HM, Karlekar MB, Keating NL, McKoy J, Medeiros BC, Mrozek E, O'Connor T, Petersdorf SH, Rugo HS, Silliman RA, Tew WP, Walter LC, Weir AB 3rd, Wildes T.

J Natl Compr Canc Netw. 2012 Feb;10(2):162-209. No abstract available.

26.

“Waiting for the other shoe to drop:” distress and coping during and after treatment for breast cancer.

Waldrop DP, O'Connor TL, Trabold N.

J Psychosoc Oncol. 2011;29(4):450-73.

PMID:
21966727
27.

Sarcoidosis mimicking metastatic breast cancer.

Bush E, Lamonica D, O'Connor T.

Breast J. 2011 Sep-Oct;17(5):533-5. doi: 10.1111/j.1524-4741.2011.01136.x. Epub 2011 Aug 9. No abstract available.

PMID:
21827559
28.

Febrile neutropenia in adjuvant docetaxel and cyclophosphamide (TC) with prophylactic pegfilgrastim in breast cancer patients: a retrospective analysis.

Ngamphaiboon N, O'Connor TL, Advani PP, Levine EG, Kossoff EB.

Med Oncol. 2012 Sep;29(3):1495-501. doi: 10.1007/s12032-011-0035-5. Epub 2011 Aug 5.

PMID:
21818673
29.

Osteonecrosis of the jaw: dental outcomes in metastatic breast cancer patients treated with bisphosphonates with/without bevacizumab.

Ngamphaiboon N, Frustino JL, Kossoff EB, Sullivan MA, O'Connor TL.

Clin Breast Cancer. 2011 Aug;11(4):252-7. doi: 10.1016/j.clbc.2011.02.001. Epub 2011 May 5.

PMID:
21729657
30.

Impact of body mass index on clinical outcomes in triple-negative breast cancer.

Ademuyiwa FO, Groman A, O'Connor T, Ambrosone C, Watroba N, Edge SB.

Cancer. 2011 Sep 15;117(18):4132-40. doi: 10.1002/cncr.26019. Epub 2011 Mar 8.

31.

Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series study.

Yao S, Sucheston LE, Millen AE, Johnson CS, Trump DL, Nesline MK, Davis W, Hong CC, McCann SE, Hwang H, Kulkarni S, Edge SB, O'Connor TL, Ambrosone CB.

PLoS One. 2011 Feb 28;6(2):e17251. doi: 10.1371/journal.pone.0017251.

32.

The effects of oncotype DX recurrence scores on chemotherapy utilization in a multi-institutional breast cancer cohort.

Ademuyiwa FO, Miller A, O'Connor T, Edge SB, Thorat MA, Sledge GW, Levine E, Badve S.

Breast Cancer Res Treat. 2011 Apr;126(3):797-802. doi: 10.1007/s10549-010-1329-6. Epub 2011 Jan 1.

PMID:
21197567
33.

Weekly ixabepilone administration in heavily pretreated metastatic breast cancer patients.

Kossoff EB, Ngamphaiboon N, Laudico TJ, O'Connor TL.

Med Oncol. 2011 Dec;28 Suppl 1:S115-20. doi: 10.1007/s12032-010-9726-6. Epub 2010 Oct 27.

PMID:
20978949
34.

NCCN Clinical Practice Guidelines Cancer-related fatigue.

Berger AM, Abernethy AP, Atkinson A, Barsevick AM, Breitbart WS, Cella D, Cimprich B, Cleeland C, Eisenberger MA, Escalante CP, Jacobsen PB, Kaldor P, Ligibel JA, Murphy BA, O'Connor T, Pirl WF, Rodler E, Rugo HS, Thomas J, Wagner LI.

J Natl Compr Canc Netw. 2010 Aug;8(8):904-31. No abstract available.

PMID:
20870636
35.

Delayed seizure associated with paclitaxel-Cremophor el in a patient with early-stage breast cancer.

O'Connor TL, Kossoff E.

Pharmacotherapy. 2009 Aug;29(8):993-6. doi: 10.1592/phco.29.8.993.

PMID:
19637953
36.

An unusual cause of cholecystitis?

Bush E, Geradts J, O'Connor T.

Am J Clin Oncol. 2005 Oct;28(5):529-30. No abstract available.

PMID:
16199997
37.

Supplemental Content

Loading ...
Support Center